SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as…
1D
-2.6%
1W
-4.8%
1M
+15.2%
6M
+14.9%
YTD
+19.7%
1Y
+23.7%
2Y
-30.6%
5Y
–
10Y
–
Next earnings date
13/11/2026 (in 27 days)
Volatility around earnings
~13% stronger price swings than usual
PRICE TARGET LOW
US$9.00
CONSENSUS
US$12.00
MEDIAN
US$12.00
PRICE TARGET HIGH
US$15.00
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 13/08/2026
P/E
10.98
P/B
2.01
EV/EBITDA
5.08
RETURN ON EQUITY
4.1%
NET MARGIN
21.7%
DEBT/EQUITY
0.18
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
2.4%
FLOAT SHARES
2,467,003
AVG. DAILY VOLUME (30D)
206,091
SBC Medical Group Holdings Incorporated is a company in the Industrials sector, Consulting Services industry, headquartered in United States.
The CEO is Yoshiyuki Aikawa, the company employs around 863 people.
The IPO was on 26/09/2022; the stock trades on NASDAQ under the ticker SBC.
1 analysts rate the stock, the consensus is Buy (as of 13/08/2026).
The average price target is US$12.00, ranging from US$9.00 to US$15.00, with a median of US$12.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 13/11/2026.
Around past earnings, price swings were roughly 13% stronger than usual.
No, SBC Medical Group Holdings currently does not pay a dividend.
Comparable stocks include Equifax, Huron Consulting Group, DKSH Holding, Caterpillar, GE Aerospace, GE Vernova, RTX and Deere & Company.
Clicking "Analyze stock" lets five strategies assess SBC Medical Group Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.